Q-Line BiotechNSE:QLINE -5.15%12 Days Inventory is 196.58 as of Mar. 2025, which is at its 10-year median of 196.58. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Q-Line Biotech ranks worse than 56.74% on this metric.
The historical rank and industry rank for Q-Line Biotech's Days Inventory or its related term are showing as below:
NSE:QLINE'
s Days Inventory Range Over the Past 10 Years
Min: 152.34 Med: 196.58 Max: 225.55
Current: 196.58
During the past 3 years, Q-Line Biotech's highest Days Inventory was 225.55. The lowest was 152.34. And the median was 196.58.
NSE:QLINE's Days Inventory is ranked worse than 56.74% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs NSE:QLINE: 196.58
Q-Line Biotech's Days Inventory
increased
from Mar. 2023 (152.34) to Mar. 2025 (196.58).
It might indicate that Q-Line Biotech's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Q-Line Biotech's Inventory Turnover for the
six
months ended in Mar. 2025 was 1.86.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Q-Line Biotech's Inventory-to-Revenue for the
six
months ended in Mar. 2025 was 0.31.
Q-Line Biotech (NSE:QLINE) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Q-Line Biotech's Inventory Turnover for the
six
months ended in Mar. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Q-Line Biotech's Inventory to Revenue for the
six
months ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Q-Line Biotech Days Inventory Related Terms
Q-Line Biotech Days Inventory Historical Data
* Premium members only.
The historical data trend for Q-Line Biotech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Q-Line Biotech Days Inventory Chart
Q-Line Biotech Annual Data
Trend
Mar23
Mar24
Mar25
Days Inventory
152.34
225.55
196.58
Q-Line Biotech Semi-Annual Data
Mar23
Mar24
Mar25
Days Inventory
152.34
225.55
196.58
NSE:QLINE vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Q-Line Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Q-Line Biotech Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Q-Line Biotech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Q-Line Biotech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Q-Line Biotech (NSE:QLINE) has a Days Inventory of 196.58 as of Mar. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Q-Line Biotech and its competitors. This is near median its historical median of 196.58. Over the past decade, Q-Line Biotech's Days Inventory has ranged from 152.34 to 225.55. According to the industry distribution chart, Q-Line Biotech ranks #446 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 56.7%.
Is Q-Line Biotech's Days Inventory too high?
Q-Line Biotech's current Days Inventory of 196.58 is near median its 10-year median of 196.58. Over the past 10 years, this metric has ranged from a low of 152.34 to a high of 225.55. The Medical Devices & Instruments industry median Days Inventory is 179.60. Q-Line Biotech's value of 196.58 is 9.5% above this industry median. Based on the distribution chart, Q-Line Biotech ranks #446 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Q-Line Biotech ranks #446 out of 786 companies for Days Inventory. This places Q-Line Biotech in the lower half of its industry. The industry median Days Inventory is 179.60. Q-Line Biotech's value of 196.58 is 9.5% above this benchmark. Historically, Q-Line Biotech's own Days Inventory has ranged from 152.34 to 225.55 over the past decade. While the company's 10-year median is 196.58 vs. the industry median of 179.60, Q-Line Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Q-Line Biotech's current Days Inventory of 196.58 is 9.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Q-Line Biotech and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Q-Line Biotech's current Days Inventory is 196.58, which is near median its own 10-year median of 196.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current Days Inventory of 196.58. The current Days Inventory is 196.58, which is near median its 10-year median of 196.58 and 9.5% above the Medical Devices & Instruments industry median of 179.60. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current Days Inventory is 196.58 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score
Get the complete analysis for NSE:QLINE
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QLINE has been successfully added to your 